Cargando…

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients

BACKGROUND: B-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients. Nevertheless, relapses are frequent after RTX, often preceded by B-cell repopulation suggesting that residual autoreactive B-cells persi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dam, Laura S., Oskam, Jelle M., Kamerling, Sylvia W. A., Arends, Eline J., Bredewold, O. W., Berkowska, Magdalena A., van Dongen, Jacques J. M., Rabelink, Ton J., van Kooten, Cees, Teng, Y. K. Onno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770159/ https://www.ncbi.nlm.nih.gov/pubmed/33384685 http://dx.doi.org/10.3389/fimmu.2020.566732

Ejemplares similares

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus
por: van Dam, Laura S., et al.
Publicado: (2019)

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results
por: Kraaij, Tineke, et al.
Publicado: (2020)

ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
por: Dirikgil, Ebru, et al.
Publicado: (2022)

A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
por: van Dam, Laura S, et al.
Publicado: (2020)

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: van Leeuwen, Jolijn R., et al.
Publicado: (2021)

Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases
por: van Dam, Laura S., et al.
Publicado: (2018)

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
por: van Schaik, Mieke, et al.
Publicado: (2022)

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

A case of mononucleosis infectiosa presenting with cholemic nephrosis
por: Bredewold, Obbo W., et al.
Publicado: (2011)

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

Rituximab for the Treatment of Pediatric Double-Positive Small-Vessel Vasculitis
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2019)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
por: Moog, Philipp, et al.
Publicado: (2015)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

TAC-TIC use of tacrolimus-based regimens in lupus nephritis
por: Kraaij, Tineke, et al.
Publicado: (2016)

Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
por: Yoneva, Tsvetelina, et al.
Publicado: (2022)

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
por: Leuning, Daniëlle G., et al.
Publicado: (2017)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2018)

Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients
por: Dirikgil, Ebru, et al.
Publicado: (2022)

An image-based flow cytometric approach to the assessment of the nucleus-to-cytoplasm ratio
por: Sebastian, Joseph A., et al.
Publicado: (2021)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
por: Bénard, Valérie, et al.
Publicado: (2021)

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Thietart, Sara, et al.
Publicado: (2022)

Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
por: Casal Moura, Marta, et al.
Publicado: (2023)

Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids
por: Gaykema, Lonneke H., et al.
Publicado: (2023)

Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
por: Sy-Go, Janina Paula T., et al.
Publicado: (2021)

A Novel Image Cytometric Method for Quantitation of Immunohistochemical Staining of Cytoplasmic Antigens
por: Guillaud, M., et al.
Publicado: (1997)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
por: Latimer, Nicholas R., et al.
Publicado: (2014)

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)

The human kidney capsule contains a functionally distinct mesenchymal stromal cell population
por: Leuning, Daniëlle G., et al.
Publicado: (2017)

Positron Emission Tomography scanning in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis
por: Kemna, Michael J., et al.
Publicado: (2015)

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis
por: McAdoo, Stephen P, et al.
Publicado: (2019)

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
por: Kant, Sam, et al.
Publicado: (2021)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
por: Weng, Xinyu, et al.
Publicado: (2022)

The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment
por: Leuning, Daniëlle G., et al.
Publicado: (2018)

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial
por: Gopaluni, Seerapani, et al.
Publicado: (2017)

Improvement of Alveolar Hemorrhaging in an Elderly and Renally Impaired Patient with Relapsing Anti-neutrophil Cytoplasmic Autoantibody-associated Vasculitis by Single Infusion of Rituximab
por: Oda, Keiko, et al.
Publicado: (2018)

Journal Club Review of “Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis”
por: Elfishawi, Mohanad
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03msf9i98ro8b722hgnrn5s0d5